Skip to main content
search
Menu
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
search
Search
Close Search
All Posts By
admin
APhA Annual Conference 2021: Don’t ‘Just Say No’: Preventing Diversion and Addressing Medical Needs
February 19, 2021
ED Visits for Opioid Poisonings Up 29%
February 10, 2021
Biden To Reverse Trump X Waiver Policy
January 25, 2021
Federal Gov’t Expands Access to Buprenorphine for OUD
January 14, 2021
Alternative Therapies in Pain Management: Evidence-Based Approaches – New York Conference
November 12, 2020
DEA Expanding Surveillance of Prescription Drug Data
November 11, 2020
DEA Supercharges Patient, Prescriber, Pharmacist Surveillance
November 9, 2020
Alternative Therapies in Pain Management: Evidence-Based Approaches – Tennessee Conference
November 5, 2020
Stigma Against OUD Medications Persists
October 20, 2020
Prepare to E-Prescribe Controlled Drugs for Medicare Participants
July 28, 2020
More
Close Menu
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
